Advertisement
Screener

Cadrenal Therapeutics, Inc. (CVKD) Return on Tangible Equity

2.8 / 5 stars · 68/120 Roast Me

Cadrenal Therapeutics, Inc. (CVKD) Return on Tangible Equity

  • 2026-06-30: Return Tang Equity -282.13%.
  • 2026-03-31: Return Tang Equity -661.53%.
  • 2025-12-31: Return Tang Equity -483.34%.
  • 2025-09-30: Return Tang Equity -525.99%.

Complete source-backed return tang equity history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Return Tang Equity

DateReturn Tang Equity
2026-06-30-282.13%
2026-03-31-661.53%
2025-12-31-483.34%
2025-09-30-525.99%
2025-06-30-328.17%
2025-03-31-209.93%
2024-12-31-143.17%
2024-09-30-222.96%
2024-06-30-156.22%
2024-03-31-78.27%
2023-12-31-108.64%
2023-09-30-139.75%
2023-06-30-384.52%
2023-03-31-288.08%

Annual Return Tang Equity

DateReturn Tang Equity
2025-12-31-483.34%
2024-12-31-143.17%
2023-12-31-108.64%
2022-12-31120.95%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)United States$0.005B
Dermata Therapeutics, Inc. (DRMA)United States$0.005B-0.62
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
AMARIN CORP PLC\UK (AMRN)$0.005B-247.24
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
Onconetix, Inc. (ONCO)United States$0.004B
Processa Pharmaceuticals, Inc. (PCSA)United States$0.005B
Aptevo Therapeutics Inc. (APVO)United States$0.003B